U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
187951187951Study of Montelukast and Its Effect on Lower Leg Growth in Children With Asthma (MK-0476-254)CompletedNo Results AvailableAsthma, BronchialDrug: Montelukast chewable tablets|Drug: Budesonide inhaler|Drug: Placebo to montelukast chewable tablets|Drug: Placebo to budesonide inhalerhttps://ClinicalTrials.gov/show/NCT00092092
187952187952A Study of MK0217A and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)CompletedNo Results AvailableOsteoporosis|Vitamin D DeficiencyDrug: MK0217A, alendronate sodium (+) cholecalciferol / Duration of Treatment: 24 weekshttps://ClinicalTrials.gov/show/NCT00092079
187953187953A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)CompletedNo Results AvailableOsteoporosis|Vitamin D DeficiencyDrug: MK0217A, alendronate sodium (+) cholecalciferol / Duration of Treatment: 15 weekshttps://ClinicalTrials.gov/show/NCT00092066
187954187954Study of Investigational Drug in Osteoporosis (MK-0217-908)CompletedNo Results AvailablePostmenopausal OsteoporosisDrug: Placebo|Drug: ibandronatehttps://ClinicalTrials.gov/show/NCT00092053
187955187955A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907)CompletedNo Results AvailableOsteoporosis, PostmenopausalDrug: MK0217, alendronate sodium/Duration of Intervention: 12 mo|Drug: Comparator: risedronate / Duration of Intervention: 12 mohttps://ClinicalTrials.gov/show/NCT00092040
187956187956A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219)CompletedNo Results AvailablePostmenopausal OsteoporosisDrug: MK0217, alendronate sodium/Duration of Treatment: 6 months|Drug: Comparator: placebo / Duration of Treatment: 6 monthshttps://ClinicalTrials.gov/show/NCT00092027
187957187957A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)CompletedNo Results AvailablePostmenopausal OsteoporosisDrug: Alendronate|Drug: Risedronate 35 mg|Dietary Supplement: Elemental Calcium|Dietary Supplement: Vitamin D|Drug: Risendronate placebo|Drug: Alendronate placebohttps://ClinicalTrials.gov/show/NCT00092014
187958187958Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung CancerCompletedNo Results AvailableCarcinoma, Non-Small-Cell LungDrug: Sunitinibhttps://ClinicalTrials.gov/show/NCT00092001
187959187959Program to Reduce Incontinence by Diet and Exercise (PRIDE)CompletedNo Results AvailableUrinary IncontinenceBehavioral: Lifestyle & Behavioral Change Program|Behavioral: Structured Education Programhttps://ClinicalTrials.gov/show/NCT00091988
187960187960Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal DialysisCompletedNo Results AvailableKidney DiseaseDrug: Zemplar Capsulehttps://ClinicalTrials.gov/show/NCT00091975
187961187961Effectiveness of Depression Treatment Following Coronary Artery Bypass SurgeryCompletedNo Results AvailableCardiovascular Diseases|Coronary Disease|Heart Diseases|DepressionBehavioral: Counseling|Drug: Pharmacotherapy|Behavioral: Usual Carehttps://ClinicalTrials.gov/show/NCT00091962
187962187962Insulin Resistance Intervention After Stroke TrialActive, not recruitingNo Results AvailableStroke|Myocardial Infarction|DiabetesDrug: pioglitazone|Drug: placebohttps://ClinicalTrials.gov/show/NCT00091949
187963187963Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited SettingsCompletedNo Results AvailableHIV Infections|TuberculosisDrug: Didanosine|Drug: Efavirenz|Drug: Lamivudine|Drug: Standard TB treatmenthttps://ClinicalTrials.gov/show/NCT00091936
187964187964Trial to Evaluate 2 Hours of Daily Patching for Amblyopia in ChildrenCompletedNo Results AvailableAmblyopiaDevice: Eye patch|Device: Spectacleshttps://ClinicalTrials.gov/show/NCT00091923
187965187965Research Into the Treatment of Anemia for Critically Ill Patients Admitted to Intensive Care Units (ICU)CompletedNo Results AvailableAnemiaDrug: Epoetin alfahttps://ClinicalTrials.gov/show/NCT00091910
187966187966Rituximab to Treat Stiff Person SyndromeCompletedNo Results AvailableStiff Person SyndromeDrug: Rituximab|Drug: rituximab or placebohttps://ClinicalTrials.gov/show/NCT00091897
187967187967Efficacy of Elevated CD4 Counts on CMV RetinitisCompletedNo Results AvailableAcquired Immunodeficiency Syndrome|Cytomegalovirus Retinitishttps://ClinicalTrials.gov/show/NCT00091884
187968187968A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease ProgressionRecruitingNo Results AvailableFamilial Hypereosinophiliahttps://ClinicalTrials.gov/show/NCT00091871
187969187969Study of Darbepoetin Alfa for the Treatment of Anemia of CancerCompletedNo Results AvailableAnemia|CancerDrug: Darbepoetin Alfa|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00091858
187970187970An Exploratory Study of AVI-4020 in Patients With Possible Acute Neuroinvasive West Nile Virus (WNV) DiseaseTerminatedNo Results AvailableWest Nile FeverDrug: AVI-4020 Injectionhttps://ClinicalTrials.gov/show/NCT00091845
187971187971Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast CancerCompletedHas ResultsBreast Cancer|Metastases|Bone Metastases in Subjects With Advanced Breast CancerBiological: Denosumab|Drug: IV Bisphosphonateshttps://ClinicalTrials.gov/show/NCT00091832
187972187972Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus AureusCompletedHas ResultsStaphylococcal Skin InfectionDrug: Telavancin|Drug: Vancomycinhttps://ClinicalTrials.gov/show/NCT00091819
187973187973Two Dose Schedules of Panitumumab in Subjects With Advanced Solid TumorsCompletedNo Results AvailableTumors|Oncology|Solid TumorsDrug: panitumumab (ABX-EGF)|Drug: Panitumumabhttps://ClinicalTrials.gov/show/NCT00091806
187974187974Study to Evaluate AMG 162 in the Prevention of Postmenopausal OsteoporosisCompletedHas ResultsPostmenopausal OsteoporosisDrug: AMG 162|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00091793
187975187975Epidemiology of Breast Arterial CalcificationCompletedNo Results AvailableCoronary Disease|Cardiovascular Diseases|Heart Diseaseshttps://ClinicalTrials.gov/show/NCT00091780
187976187976Genetic Studies in Difficult to Treat Asthma: TENORCompletedNo Results AvailableAsthma|Lung Diseaseshttps://ClinicalTrials.gov/show/NCT00091767
187977187977Atherosclerosis, Plaque and CVD in CommunitiesCompletedNo Results AvailableAtherosclerosis|Cardiovascular Diseases|Heart Diseases|Cerebrovascular Accident|Coronary Arteriosclerosis|Coronary Diseasehttps://ClinicalTrials.gov/show/NCT00091754
187978187978Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected SubjectsCompletedNo Results AvailableHIV InfectionDrug: Etanercept (Enbrel)https://ClinicalTrials.gov/show/NCT00091741
187979187979Hormonal Contraception and Risk of Chlamydia and GonorrheaTerminatedNo Results AvailableChlamydia Infection|Neisseriaceae InfectionDrug: Depo Medroxyprogesterone acetate|Drug: Combined oral contraceptiveshttps://ClinicalTrials.gov/show/NCT00091728
187980187980Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class IICompletedNo Results AvailablePulmonary HypertensionDrug: bosentan|Drug: placebohttps://ClinicalTrials.gov/show/NCT00091715

* Görseller ve İçerik tekif hakkına sahip olabilir